| Date | Title | Description |
| 19.01.2022 | Inside crypto exchange FTX’s new venture fund | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox.
FTX wants to move fast.
Paid Content How to update cybersecurity in the face of potential attacks... |
| 19.01.2022 | Inside crypto exchange FTX’s new venture fund | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox.
FTX wants to move fast.
Paid Content Why today's marketers need strong collaboration tools From O... |
| 19.01.2022 | UCB to Acquire Zogenix in Deal Valued at Up to $1.9 Billion | By Cristina Roca
UCB SA has agreed to buy biopharmaceutical company Zogenix Inc. in a deal worth up to about $1.9 billion.
The two companies said Wednesday that UCB will launch a tender offer on all outstanding Zogenix shares for $26 a shar... |
| 19.01.2022 | UCB Media Room: UCB to acquire Zogenix | https://mb.cision.com/Public/18595/logo/86a99b25f755738d_org.jpg ** UCB to acquire Zogenix ------------------------------------------------------------ =C2=B7 Transaction broadens and builds upon UCB=E2=80=99s role as a leader = in, and our... |
| 19.01.2022 | UCB to acquire Zogenix | BRUSSELS and EMERYVILLE, Calif., Jan. 19, 2022 /PRNewswire/ -- Regulated information – Inside information – UCB (Euronext: UCB) and Zogenix (NASDAQ: ZGNX) announced today that the companies have entered into a definitive agreement under whi... |
| 09.08.2021 | Zogenix Dravet Syndrome Photo Diary Contest Raises $50,000 for Dravet Syndrome and Epilepsy Foundations | |
| 26.08.2019 | Zogenix Acquires Modis Therapeutics, for $250M | Zogenix, Inc. (NASDAQ: ZGNX), an Emeryville, California-based pharmaceutical company developing rare disease therapies, acquired Modis Therapeutics, Inc., an Oakland, CA-based biopharmaceutical company focused on developing novel therapies ... |
| 30.10.2014 | West Coast Biotech Roundup: Amgen, Inslee, Fibrogen, Receptos & More | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
Amgen keeps adding to the layoffs, the governor of Washington has a lot to say to Xconomy about his state’s life sciences industry, and San Francisco’s Fibrogen hopes to crank... |
| 15.04.2014 | Zohydro ban: Disagreeing with Governor Patrick | Massachusetts Governor Deval Patrick is trying to ban Zohydro ER, a new prescription painkiller, under a state of emergency he’s declared to combat opiate abuse. I agree with the Governor that opiate addiction is a huge problem in Massachus... |
| 05.11.2013 | Zogenix Announces $60M Stock Offering | Right on the heels of the Food and Drug Administration’s approval of the narcotic painkiller Zohydro, San Diego-based Zogenix Inc. has announced a $60 million public offering of its stock.
Shares for the company (Nasdaq: ZGNX) fell 13 perce... |
| 14.09.2012 | Needleless syringe maker presses on, raising $2.8 million amid U.S. flu vaccine hurdle | PharmaJet is the maker of the Stratis system, a needle-free device used to deliver drugs, including vaccines, through the skin. It can deliver 0.5 mL of a drug — the dose for vaccines including hepatitis A and B, poliovirus, seasonal flu, H... |
| 07.09.2010 | Zogenix files for $90 million IPO | Zogenix Inc. is attempting to raise $90 million through an initial public offering.
The San Diego-based company said it plans utilize the new funds to help commercialize its Sumavel DosePro drug-device combination and the clinical advanceme... |
| 07.09.2010 | California’s Zogenix seeks $90M IPO to advance pain drug, device | At the close of the quarter ending June 30, the company brought in $6.1 million in revenues from the Sumavel DosePro device system, but in the itemized risk section of the filing, the company listed net losses of $45.9 million in 2009 and $... |
| 13.07.2010 | Zogenix Secures $35m Debt Facility; $15m Equity Investment | Zogenix, Inc., an Emeryville and San Diego, Calif.-based pharmaceutical company, has secured a $35m debt facility and a $15m equity investment.
The debt facility, led by Oxford Finance Corporation with participation from Silicon Valley Bank... |
| 13.07.2010 |
Zogenix Gets $50M in Debt, Equity
| San Diego-based Zogenix announced today that it has just raised $35M in debt, and $15M in equity funding. The developer of biopharmaceuticals said that the $35M in debt came from Oxford Finance Corporation and Silicon Valley Bank, and was s... |
| 07.12.2009 | Zogenix Increases Raises $35M in Second Tranche of Increased to $71M Series B Financing | Zogenix, Inc., an Emeryville and San Diego, CA-based pharmaceutical company, announced that it has closed a $35m second tranche of a Series B preferred stock financing.
The Series B round was increased from $51m, previously announced in Sep... |
| 23.09.2009 | USA, Zogenix Closes $51M in Series B Preferred Stock Financing | Zogenix, Inc., a pharmaceutical company focused on the development and commercialization of medicines to treat neuroscience disorders and pain, completed a $51m Series B preferred stock financing round.
The round was co-led by Clarus Ventur... |
| 23.09.2009 |
Zogenix Gets $51M In Series B
| San Diego-based Zogenix, a pharmaceutical firm developing treatments for neuroscience disorders and pain, said Wednesday that it has completed a $51M, Series B preferred stock financing. The firm said that the round was led by Clarus Ventur... |
| 28.07.2008 |
Zogenix Gets $18M In Debt
| San Diego-based Zogenix, a developer of specialty pharmaceuticals, said Monday that it has raised $18M in a secured loan facility. The loan came from Oxford Finance Corporation and CIT Healthcare LLC. Zogenix said the funding will go toward... |
| 21.03.2008 | Life-science briefing: Friday, March 21, 2008 | TODAY’S HEADLINES:
Cancer-vaccine maker MabVax gets $8M (release)
“Needle-free” drug maker Zogenix files for $86M IPO (Edgar)
“Needle-free” drug maker Zogenix files for $86M IPO — Zogenix, a San Diego developer of “needle-free” drug-deliver... |
| 09.01.2008 | Life sciences briefing: Wednesday, Jan. 9, 2008 | TODAY’S HEADLINES:
MRI image-analysis firm Confirma receives $18M (release)
Specialty pharma Zogenix raises $18M (release)
Arcion pulls in $8.8M for topical pain gel (release)
Bayhill Therapeutics files for $87M IPO (Edgar)
Peakdale Molecul... |
| 28.08.2006 |
Zogenix Raises $60M
| San Diego-based Zogenix has raised $60M in a Series A financing, the firm announced this morning. The company received funding from Clarus Ventures and Domain Associates, along with additional investors BA Venture Partners, Thomas, McNerney... |
| 28.08.2006 | Zogenix, Inc. Raises $60 Million in Series A Venture Financing; Names Board of Directors | SAN DIEGO & HAYWARD, Calif.– –Aug. 28, 2006 – Zogenix, Inc., a privately held pharmaceutical company focused on medicines to treat CNS disorders and pain, today announced that the company has raised $60 …
VentureBeat VentureBeat's missi... |
| - | California’s Zogenix seeks $90M IPO to advance pain drug, device | Zogenix Inc. is attempting to raise $90 million through an initial public offering.
The San Diego, California-based company said in a Securities & Exchange Commission filing it plans use the new money to commercialize its Sumavel DosePr... |
| - | Needleless syringe maker presses on, raising $2.8 million amid U.S. flu vaccine hurdle | When the U.S. Food and Drug Administration warned healthcare practitioners last fall that no flu vaccines had been approved to be administered via jet injection, the companies that spent years developing needleless syringes with this techno... |
| - | Zohydro ban: Disagreeing with Governor Patrick | Massachusetts Governor Deval Patrick is trying to ban Zohydro ER, a new prescription painkiller, under a state of emergency he’s declared to combat opiate abuse. I agree with the Governor that opiate addiction is a huge problem in Massachus... |
